Physician profile
James Dahm
NPI 1649763947
$5,692.72
in general payments reported to CMS, 2019-2025
15 companies · $773 in 2025
The $773 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $355 · 2021: $510 · 2022: $940 · 2023: $2,012 · 2024: $832 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,421 · Education: $534 · Travel and Lodging: $491 · Consulting Fee: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,420.55 |
| Education | $533.98 |
| Travel and Lodging | $491.23 |
| Consulting Fee | $171.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,643.93 | 2019-2024 | |
| Stryker Corporation | $1,309.54 | 2020-2025 | Mako, Variax, Blueprint Patient Specific Instrumentation |
| Axogen | $756.86 | 2023 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Medartis INC. | $712.98 | 2023 | Aptus |
| Acumed LLC | $400.77 | 2024-2025 | Acumed, Acumed, Innate Implant |
| Orthopediatrics Corp. | $232.48 | 2023 | |
| Kerecis Limited | $162.52 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $154.74 | 2025 | Velys, Attune, Actis |
| Zimmer Biomet Holdings, INC. | $98.07 | 2023 | Juggerknotless Soft Anchor |
| Smith+Nephew, INC. | $87.36 | 2025 | Real Intelligence |
| Djo, LLC | $54.89 | 2024 | Cmf |
| Crossroads Orthopedics, LLC | $25.40 | 2023 | |
| Joint Active Systems, INC. | $19.95 | 2022 | |
| Enduromed, LLC | $18.24 | 2025 | |
| Checkpoint Surgical, INC | $14.99 | 2024 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dahm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.